Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. (ORKA) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 19 transactions totaling $214.3K, demonstrating a bearish sentiment with -$214.3K in net insider flow. The most recent transaction on Jan 23, 2026 involved a transaction of 130,000 shares valued at $0.
ORKA Insider Activity Summary
Who Is Buying ORKA Stock?
No significant insider buying has been recorded for ORKA in the recent period.
Who Is Selling ORKA Stock?
No significant insider selling has been recorded for ORKA in the recent period.
Is Oruka Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ORKA is bearish with an Insider Alignment Score of 0/100 and a net flow of -$214.3K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ORKA Frequently Asked Questions
Understanding ORKA Insider Activity
Insider trading at Oruka Therapeutics, Inc. (ORKA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading ORKA stock, having executed 19 transactions in the past 90 days. The most active insider is Tomas Kiselak (Executive), who has made 2 transactions totaling $11.3M.
Related Tools
Track Oruka Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ORKA file new Form 4 transactions